google_counter
Chemotherapy of nephroblastoma (Wilms tumor) (1 course) (561513) | University Hospital Ulm - BookingHealth
or Registration
Forgot your password?
Mode
Font size
{"translation_price":"50","translation_doc_price":"40","child_coefficient":"1.1","transfer_price":"2.00","transfer_price_vip":"5.00","constant_transfer_price_vip":350,"constant_transfer_price":150,"constant_transfer_distanse":60,"type":"treatment","program_full_story":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>clinical history taking<\/li>\n\t<li>review of medical records<\/li>\n\t<li>physical examination<\/li>\n\t<li>laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>general urine analysis<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>TSH-basal, fT3, fT4<\/li>\n\t\t<li>tumor markers<\/li>\n\t\t<li>inflammation indicators<\/li>\n\t\t<li>indicators of blood coagulation<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>CT scan \/ MRI of the abdomen and retriperitoneum<\/li>\n\t<li>abdominal and retroperitoneal ultrasound scan<\/li>\n\t<li>1 course of chemotherapy<\/li>\n\t<li>nursing services<\/li>\n\t<li>consultations of related specialists<\/li>\n\t<li>treatment by head doctor and leading experts<\/li>\n\t<li>explanation of individual treatment plan<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the doctor will conduct a clinical examination and go through the results of previous laboratory tests and instrumental examinations. After that, you will undergo an additional examination, including laboratory assessment of liver and kidney function, ultrasound scan. Based on the received results, the doctor will elaborate the chemotherapy regimen. If necessary, related medical specialists will be involved in the elaboration of a treatment regimen (tumor board).<\/p>\n\n<p style=\"text-align:justify\"><strong>Chemotherapy&nbsp;<\/strong>is carried out as the inpatient procedure, with&nbsp;mandatory admission to the hospital. After the placement of a venous catheter, you will stay in a comfortable ward. An infusion system will be connected to the catheter, through which the required drug or a drug combination will be administered. All drugs are administered by intravenous drip, slowly, so the total duration of the infusion can be up to several hours. All this time, doctors and nurses will monitor your health condition closely.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the course of chemotherapy<\/strong>, you will stay under medical supervision in the ward for a few more hours. After the completion of the chemotherapy course you will receive the medical report with detailed recommendations regarding further treatment. In the future, you will be able to have a distant consultation with your attending physician and schedule the next course of chemotherapy, if necessary.<\/p>\n<\/div><div class=\"program_required_documents mt-4\"><h4>Required documents<\/h4><ul>\n\t<li style=\"text-align: justify;\">Medical records<\/li>\n\t<li style=\"text-align: justify;\">MRI\/CT scan (not older than 3 months)<\/li>\n\t<li style=\"text-align: justify;\">Biopsy results (if available)<\/li>\n<\/ul>\n<\/div>","program_full_story_crm":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>clinical history taking<\/li>\n\t<li>review of medical records<\/li>\n\t<li>physical examination<\/li>\n\t<li>laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>general urine analysis<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>TSH-basal, fT3, fT4<\/li>\n\t\t<li>tumor markers<\/li>\n\t\t<li>inflammation indicators<\/li>\n\t\t<li>indicators of blood coagulation<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>CT scan \/ MRI of the abdomen and retriperitoneum<\/li>\n\t<li>abdominal and retroperitoneal ultrasound scan<\/li>\n\t<li>1 course of chemotherapy<\/li>\n\t<li>nursing services<\/li>\n\t<li>consultations of related specialists<\/li>\n\t<li>treatment by head doctor and leading experts<\/li>\n\t<li>explanation of individual treatment plan<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the doctor will conduct a clinical examination and go through the results of previous laboratory tests and instrumental examinations. After that, you will undergo an additional examination, including laboratory assessment of liver and kidney function, ultrasound scan. Based on the received results, the doctor will elaborate the chemotherapy regimen. If necessary, related medical specialists will be involved in the elaboration of a treatment regimen (tumor board).<\/p>\n\n<p style=\"text-align:justify\"><strong>Chemotherapy&nbsp;<\/strong>is carried out as the inpatient procedure, with&nbsp;mandatory admission to the hospital. After the placement of a venous catheter, you will stay in a comfortable ward. An infusion system will be connected to the catheter, through which the required drug or a drug combination will be administered. All drugs are administered by intravenous drip, slowly, so the total duration of the infusion can be up to several hours. All this time, doctors and nurses will monitor your health condition closely.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the course of chemotherapy<\/strong>, you will stay under medical supervision in the ward for a few more hours. After the completion of the chemotherapy course you will receive the medical report with detailed recommendations regarding further treatment. In the future, you will be able to have a distant consultation with your attending physician and schedule the next course of chemotherapy, if necessary.<\/p>\n<\/div>","is_ambulant":"0","bh_fee":"0","only_for_children":"0","no_service":"0","with_prepayment":"1","show_calculator":"1","paket_type":"1","btn_type":"2","clinic_icon":"5ff71ab6e4686.jpg","city":"Ulm","clinic_site":"http:\/\/www.uniklinik-ulm.de\/","department_recommend":"0","country":"Germany","country_id":"1","clinic_name":"University Hospital Ulm","cinic_name":"University Hospital Ulm","department_id":"3246","duration":"7","direction":"Cancer","min_duration":0,"clinic_id":"835","paketPrice":4900,"paket":"<ul>\n <li>Interpreter up to 12 hours<\/li>\n <li>Translation up to 10 pages<\/li>\n <li>Visa support<\/li>\n\n \n<\/ul>","title":"Chemotherapy of nephroblastoma (Wilms tumor) (1 course)","price":{"val":12743.57,"type":"val"},"price_surcharge":0,"price_surcharge_clear":0,"extra_service_clinic":[{"id":"need_to_use_head_doctor","title":"Treatment by leading experts","type":"val","val":"2893.38","req":0},{"id":"1_person_room","title":" Single room (whole period)","parent":"duration","type":"count_val","val":"41.00"},{"id":"2_person_room","title":" double room (whole period)","parent":"duration","type":"count_val","val":"16.00"},{"id":"attendant_place","title":"Accommodation for the accompanying person ","parent":"duration","type":"count_val","val":"90.00"}],"extra_service":[],"translation_hours":"0","translation_doc_count":null,"roads":[{"id":"19","distance":"79","airport_title":"Stuttgart"},{"id":"2","distance":"163","airport_title":"Munich"},{"id":"6","distance":"277","airport_title":"Frankfurt a.M."}],"pakets":[],"lang":{"day":"Day","days":"days","ambulatory":"Outpatient","stationaryProgram":"Inpatient"}}

Chemotherapy of nephroblastoma (Wilms tumor) (1 course) in University Hospital Ulm

University Hospital Ulm

Ulm, Germany
Program id # 561513
Doctor photo
Prof. Dr. med. Holger Cario
Department of Pediatric Oncology and Hematology
Specialized in: pediatric hematology and oncology
Specialization Curriculum vitae

The program includes:

  • Initial presentation in the clinic
  • clinical history taking
  • review of medical records
  • physical examination
  • laboratory tests:
    • complete blood count
    • general urine analysis
    • biochemical analysis of blood
    • TSH-basal, fT3, fT4
    • tumor markers
    • inflammation indicators
    • indicators of blood coagulation
  • CT scan / MRI of the abdomen and retriperitoneum
  • abdominal and retroperitoneal ultrasound scan
  • 1 course of chemotherapy
  • nursing services
  • consultations of related specialists
  • treatment by head doctor and leading experts
  • explanation of individual treatment plan

How program is carried out

During the first visit, the doctor will conduct a clinical examination and go through the results of previous laboratory tests and instrumental examinations. After that, you will undergo an additional examination, including laboratory assessment of liver and kidney function, ultrasound scan. Based on the received results, the doctor will elaborate the chemotherapy regimen. If necessary, related medical specialists will be involved in the elaboration of a treatment regimen (tumor board).

Chemotherapy is carried out as the inpatient procedure, with mandatory admission to the hospital. After the placement of a venous catheter, you will stay in a comfortable ward. An infusion system will be connected to the catheter, through which the required drug or a drug combination will be administered. All drugs are administered by intravenous drip, slowly, so the total duration of the infusion can be up to several hours. All this time, doctors and nurses will monitor your health condition closely.

After the course of chemotherapy, you will stay under medical supervision in the ward for a few more hours. After the completion of the chemotherapy course you will receive the medical report with detailed recommendations regarding further treatment. In the future, you will be able to have a distant consultation with your attending physician and schedule the next course of chemotherapy, if necessary.

Required documents

  • Medical records
  • MRI/CT scan (not older than 3 months)
  • Biopsy results (if available)

Service

Price from:
Type of program :
Price for 1 day:
Expected duration of the program:
The minimum duration of the program:
Select

You may also book:

Hospital directly:
Saving:
Guarantee BookingHealth Price from:

About the department

The Department of Pediatric Oncology and Hematology at the University Hospital Ulm provides the full range of medical services in the areas of its specialization. The highly qualified doctors at the medical facility diagnose and treat solid malignant tumors in children, such as brain tumors, neuroblastomas, nephroblastomas, Ewing's sarcomas, osteosarcomas, and soft tissue sarcomas. The department also provides medical care to young patients with malignant blood diseases. Of particular interest is the treatment of leukemia and myelodysplastic syndrome. Medical services are provided in strict accordance with the current clinical protocols and recommendations of the German Society of Pediatric Oncology (GPO). The most effective, proven therapeutic methods are used in clinical practice to achieve long-term results. The department's specialists most often perform chemotherapy and immunotherapy. Autologous bone marrow transplants can also be carried out if clinically indicated. The procedure is performed in a specialized center at the University Hospital Ulm. When treating young patients, the department's oncologists collaborate closely with pediatric surgeons, neurosurgeons, radiation therapists, orthopedists, and other experts. The department has 20 beds available for the hospitalization of children. The department is headed by Prof. Dr. med. Holger Cario.

Brain tumors are the most common malignant solid neoplasms in childhood. The department's team of pediatric oncologists treats young patients with gliomas, medulloblastomas, and ependymomas. The specialists also deal with the management of benign brain tumors, including craniopharyngiomas, meningiomas, and neurocytomas. Tumor growth often leads to increased intracranial pressure, resulting in various unpleasant symptoms in children, such as constant headaches, nausea and vomiting, coordination and gait abnormalities, visual impairment, seizures, etc. The main method of detecting malignant brain tumors is magnetic resonance imaging. The doctors also conduct a physical examination, an assessment of the child's neurological status, laboratory tests, and a biopsy with a follow-up histological examination. The first-line treatment for detected brain tumors is surgery. The surgical intervention is usually supplemented with conservative methods. Pediatric oncologists carry out chemotherapy, targeted therapy, and immunotherapy. Radiation therapy may also be performed if clinically indicated. After the completion of the basic course of treatment, neurological rehabilitation may be required. This is aimed at restoring speech, motor functions, and cognitive abilities. The treatment regimen for brain cancer is developed individually for each child. Such an approach allows the doctors to achieve the best results and eliminate neurological deficits.

The department's clinical focus is the treatment of leukemias, malignant diseases of the hematopoietic system. The main symptoms of this group of diseases include general weakness, fatigue, loss of appetite, fever of unknown origin, immunodeficiency, and symptoms of intoxication. The diagnosis involves a physical examination, extensive laboratory testing, and a bone marrow aspiration (a painless procedure performed under anesthesia). In some cases, imaging examinations such as CT, MRI, ultrasound, and X-ray scans may also be prescribed. With all the diagnostic data, the department's oncologists proceed with the development of the optimal treatment regimen. An individually prescribed course of chemotherapy is mainly carried out to treat leukemia in children. Depending on the particular clinical case, oral or intravenous administration of chemotherapeutic agents is supplemented with targeted therapy and/or radiation therapy. The last-line treatment for leukemia is high-dose chemotherapy followed by a bone marrow transplant. This treatment option is indicated for young patients with a complex course of the disease.

The medical facility also successfully treats myelodysplastic syndromes, which lead to impaired blood cell maturation. Children with this pathology suffer from weakness and fatigue, fever, pale skin, and an increased tendency to bleed. To confirm the diagnosis, the department's pediatric oncologists perform general and biochemical blood tests and a bone marrow puncture. If clinically indicated, genetic tests and imaging examinations may also be required. Treatment tactics depend on the aggressiveness of the disease. In cases of myelodysplastic syndrome with low aggressiveness, the department's specialists carry out chemotherapy in combination with immunosuppressive therapy. In cases of high aggressiveness of the hematologic pathology, effective results can be achieved through chemotherapy and a bone marrow transplant.

The department specializes in the treatment of the following diseases:

  • Solid tumors of various locations
    • Brain tumors
      • Malignant tumors: gliomas, medulloblastomas, and ependymomas
      • Benign tumors: craniopharyngiomas, meningiomas, and neurocytomas
    • Neuroblastomas
    • Nephroblastomas
    • Ewing's sarcomas
    • Osteosarcomas
    • Soft tissue sarcomas
  • Hematopoietic disorders
    • Leukemia
    • Myelodysplastic syndromes
  • Other diseases

The department's range of diagnostic and therapeutic services includes the following:

  • Diagnostic services
    • Morphological and immunological examinations of blood, bone marrow, and tumor tissue
    • Molecular analysis of blood, bone marrow, and tumor tissue
    • Bone marrow puncture with a cytological examination
  • Therapeutic services
    • Chemotherapy
    • Immunotherapy
    • Bone marrow transplant
  • Other medical services

Curriculum vitae

Higher Education and Professional Career

  • 1987- 1994 Medical studies, Faculty of Medicine, Humboldt University of Berlin.
  • 1994 Thesis defense, Faculty of Medicine, Humboldt University of Berlin.
  • 1995 Internship and Residency, Department of Pediatric and Adolescent Medicine, University Hospital Ulm.
  • 2001 Board certification in Pediatric and Adolescent Medicine.
  • 2006 Board certification in Pediatric Hematology and Oncology.
  • Since 2009 Senior Physician, Department of Pediatric Oncology and Hematology, University Hospital Ulm.
  • 2009 Habilitation. Subject: "Molecular basis and clinical manifestations of congenital erythrocytosis and polycythemia in childhood and adolescence."
  • 2012 Extraordinary Professorship.

Clinical and Research Focuses

  • Anemias, in particular thalassemia, and other congenital and acquired anemias.
  • Congenital and acquired erythrocytosis and related pathologies.

Photo of the doctor: (c) Universitätsklinikum Ulm

About hospital

The University Hospital Ulm is an advanced medical complex that provides patients with high-class medical care using the very latest scientific achievements. The medical facility has been performing successful clinical activities for more than 40 years and has long earned an excellent reputation throughout Europe. The hospital regularly demonstrates high treatment success rates, takes an active part in the training of medical students, and works tirelessly on promising research projects. 

The university hospital consists of 29 specialized departments and 16 scientific institutes, where more than 7,000 highly qualified employees work for the benefit of their patients. More than 55,000 inpatients and about 300,000 outpatients are treated here every year. The hospital has 1,274 beds. The medical team of the hospital is focused on providing personalized medical services using the most modern and sparing diagnostic and treatment methods.

The University Hospital Ulm is the largest medical complex in the region, and practically all areas of modern medicine are represented here. Transplantology and oncology are among the priority areas of clinical activity in the medical facility. The hospital holds leading positions in the world in bone marrow transplantation. In addition, the hospital has advanced experience in cancer treatment. The Comprehensive Cancer Center is recognized as the leading facility of this kind in the country, and it is certified by the German Cancer Society (DKG). It provides effective treatment for various types of cancer. The center also offers innovative CAR T-cell therapy. In addition, the Cancer Center is actively engaged in research activities to improve available treatment methods and develop innovative therapeutic techniques to fight cancer.

Along with the use of advanced technologies, doctors show respect, understanding, and a humane attitude toward the patient. The medical team includes competent psychologists, who are always ready to provide assistance and support to the patients and their families during the therapeutic process.

Photo: (с) depositphotos

Accommodation in hospital

Patients rooms

The patients of the University Hospital Ulm live in comfortable single and double rooms with a modern design and light colors. All patient rooms have an ensuite bathroom with a toilet and a shower. The patient room furnishings include a comfortable automatically adjustable bed, a bedside table, a wardrobe, a table and chairs, a telephone, a radio, and a TV. Wi-Fi access is also available in patient rooms.

The hospital also offers enhanced-comfort rooms, which additionally have a safe, a refrigerator, and upholstered furniture. The bathroom in the enhanced-comfort room has changeable towels, a cosmetic mirror, a hairdryer, and toiletries.

Meals and Menus

Patients and their accompanying person are offered three meals a day: breakfast, lunch, and dinner. The patient and accompanying person have a choice of three menus every day, including a vegetarian menu. Patients staying in the enhanced-comfort rooms are also offered light snacks, fruits, desserts, and hot and cold drinks in the comfortable lounge area.

If, for some reason, you do not eat all the foods, you will be offered an individual menu. Please inform the medical staff about your dietary preferences prior to treatment.

Further details

Standard rooms include:

Shower

Toilet

Wi-Fi

TV

Religion

The hospital has a chapel where Catholic and Protestant services are held weekly. The services are also broadcast on the internal television channel of the hospital. The chapel is open 24 hours a day for visits and prayers.

The services of other religious representatives are available upon request.

Accompanying person

Your accompanying person may stay with you in your patient room or at the hotel of your choice during the inpatient program.

Hotel

You may stay at the hotel of your choice during the outpatient program. Our managers will support you for selecting the best option.